← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 1, 2015Last known activity
Jul 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (15 distinct, 8 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (11 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT06138249Lead sponsorN/AJul 1, 2023
- NCT06138236Lead sponsorEarly Phase 1Jul 1, 2023
- NCT06768177Lead sponsorN/AApr 1, 2023
- NCT06955546Sponsor investigatorN/AJan 7, 2023
- NCT06955546Lead sponsorN/AJan 7, 2023
- NCT04847791Overall official - principal investigatorN/AJan 14, 2021
- NCT04664712Lead sponsorN/ASep 11, 2019
- NCT03764605Overall official - principal investigatorPhase 3Jan 30, 2019
- NCT02275169Study directorPhase 3Feb 1, 2015
Details
- Last known activity
- Jul 1, 2023